By interacting directly with NSCLC cell Smad family members (Smad2, Smad3, and Smad4), MELK inhibits EMT and increases tumor cell motility, invasion, and metastasis (Cheng et al. 2017). This evidence concerns the gene SMAD3 and non-small cell lung carcinoma.